Genentech, Inc. et al v. Pfizer, Inc. > Summary

Court Case Number 1:17-cv-01672

Filing Date Nov 17, 2017

Termination Date Dec 4, 2018

Court Delaware District Court

Status Dismissed - Settled

JudgesColm F. Connolly

Cause

35:271 Patent Infringement

Related Patents

Doc No	Title	Issue date
09714293	Production of proteins in glutamine-free cell culture media	Jul 25, 2017
09493744	Methods for viral inactivation and other adventitious agents	Nov 15, 2016
09487809	Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase	Nov 8, 2016
09428766	Protein expression from multiple nucleic acids	Aug 30, 2016
09249218	Protein purification	Feb 2, 2016
08822655	Pre-filtration adjustment of buffer solutes	Sep 2, 2014
08771988	Protein expression from multiple nucleic acids	Jul 8, 2014
08710196	Protein purification	Apr 29, 2014
08691232	Extending time to disease progression or survival in cancer patients	Apr 8, 2014
08633302	Variable tangential flow filtration	Jan 21, 2014
08574869	Prevention of disulfide bond reduction during recombinant production of polypeptides	Nov 5, 2013
08512983	Production of proteins in glutamine-free cell culture media	Aug 20, 2013
08460895	Method for producing recombinant proteins with a constant content of pCO2 in the medium	Jun 11, 2013
08440402	Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy	May 14, 2013
08425908	Treatment with anti-ErbB2 antibodies	Apr 23, 2013
08314225	Heavy chain mutant leading to improved immunoglobulin production	Nov 20, 2012
08076066	Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapy	Dec 13, 2011
08044017	Protein purification	Oct 25, 2011
07993834	Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy	Aug 9, 2011
07923221	Methods of making antibody heavy and light chains having specificity for a desired antigen	Apr 12, 2011
07892549	Treatment with anti-ErbB2 antibodies	Feb 22, 2011
07846441	Treatment with anti-ErbB2 antibodies	Dec 7, 2010
07807799	Reducing protein A leaching during protein A affinity chromatography	Oct 5, 2010
07501122	Treatment with anti-ErbB2 antibody combinations	Mar 10, 2009
07485704	Reducing protein A leaching during protein A affinity chromatography	Feb 3, 2009
07449184	Fixed dosing of HER antibodies	Nov 11, 2008
07390660	Methods for growing mammalian cells in vitro	Jun 24, 2008
07371379	Dosages for treatment with anti-ErbB2 antibodies	May 13, 2008
06716602	Metabolic rate shifts in fermentations expressing recombinant proteins	Apr 6, 2004
06627196	Dosages for treatment with anti-ErbB2 antibodies	Sep 30, 2003
06620918	Separation of polypeptide monomers	Sep 16, 2003
06610516	Cell culture process	Aug 26, 2003
06586206	Methods for making recombinant proteins using apoptosis inhibitors	Jul 1, 2003
06489447	Protein purification	Dec 3, 2002
06417335	Protein purification	Jul 9, 2002
06407213	Method for making humanized antibodies	Jun 18, 2002
06339142	Protein purification	Jan 15, 2002
06331415	Methods of producing immunoglobulins, vectors and transformed host cells for use therein	Dec 18, 2001
06242177	Methods and compositions for secretion of heterologous polypeptides	Jun 5, 2001
06121428	Protein recovery	Sep 19, 2000

Lawsuits

Genentech, Inc. et al v. Pfizer, Inc. > Summary

Plaintiff

Defendant

Plaintiff Attorneys

Defendant Attorneys

Counter Defendant

Counter Claimant

Cause

Related Patents